Pages that link to "Q43649929"

The following pages link to Expression of matrix metalloproteinase-2 and -14 persists during early resolution of experimental liver fibrosis and might contribute to fibrolysis (Q43649929):

Displaying 38 items.

• Role of MMP-2 and MMP-9 and their natural inhibitors in liver fibrosis, chronic pancreatitis and non-specific inflammatory bowel diseases (Q27012575) (← links)
• Selenium supplementation decreases hepatic fibrosis in mice after chronic carbon tetrachloride administration (Q33805479) (← links)
• Spatial and temporal transcriptomics of Schistosoma japonicum-induced hepatic granuloma formation reveals novel roles for neutrophils (Q34741353) (← links)
• Adiponectin reduces hepatic stellate cell migration by promoting tissue inhibitor of metalloproteinase-1 (TIMP-1) secretion (Q35126638) (← links)
• Regression of allograft airway fibrosis: the role of MMP-dependent tissue remodeling in obliterative bronchiolitis after lung transplantation (Q35168136) (← links)
• Early activated hepatic stellate cell-derived molecules reverse acute hepatic injury (Q35375422) (← links)
• Increased Expression of TGF-β Signaling Components in a Mouse Model of Fibrosis Induced by Submandibular Gland Duct Ligation (Q35587144) (← links)
• Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ (Q35649446) (← links)
• Matrix metalloproteinases in liver injury, repair and fibrosis (Q35830977) (← links)
• Reversal of hepatic fibrosis -- fact or fantasy? (Q36382260) (← links)
• Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategies (Q36561567) (← links)
• Loss of steroid receptor co-activator-3 attenuates carbon tetrachloride-induced murine hepatic injury and fibrosis (Q36749958) (← links)
• Telmisartan, an AT1 receptor blocker and a PPAR gamma activator, alleviates liver fibrosis induced experimentally by Schistosoma mansoni infection (Q37071406) (← links)
• Genesis of hepatic fibrosis and its biochemical markers. (Q37210050) (← links)
• Interleukin-1 participates in the progression from liver injury to fibrosis (Q37231308) (← links)
• Matrix metalloproteinases in inflammatory pathologies of the horse (Q37330914) (← links)
• Deficiency of nicotinamide adenine dinucleotide phosphate, reduced form oxidase enhances hepatocellular injury but attenuates fibrosis after chronic carbon tetrachloride administration (Q37381842) (← links)
• Biochemical insights into the role of matrix metalloproteinases in regeneration: challenges and recent developments (Q37477458) (← links)
• Role of host genetics in fibrosis. (Q37644559) (← links)
• Models and mechanisms of fibrosis resolution (Q37834043) (← links)
• Curcumin targets multiple pathways to halt hepatic stellate cell activation: updated mechanisms in vitro and in vivo (Q38297265) (← links)
• Fibronectin peptides as potential regulators of hepatic fibrosis through apoptosis of hepatic stellate cells. (Q38979803) (← links)
• Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol mediated liver fibrosis in mice (Q39326587) (← links)
• Resolution of liver fibrosis by isoquinoline alkaloid berberine in CCl₄-intoxicated mice is mediated by suppression of oxidative stress and upregulation of MMP-2 expression (Q42158636) (← links)
• Hydroxyproline-containing collagen analogs trigger the release and activation of collagen-sequestered proMMP-2 by competition with prodomain-derived peptide P33-42. (Q42577257) (← links)
• Treatment of pancreatic fibrosis with siRNA against a collagen-specific chaperone in vitamin A-coupled liposomes. (Q45914730) (← links)
• An ultrasound and histomorphological analysis of experimental liver cirrhosis in rats. (Q46188878) (← links)
• Lack of inducible nitric oxide synthase leads to increased hepatic apoptosis and decreased fibrosis in mice after chronic carbon tetrachloride administration (Q46572462) (← links)
• Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone (Q46674198) (← links)
• Reversal of liver fibrosis by the antagonism of endocannabinoid CB1 receptor in a rat model of CCl(4)-induced advanced cirrhosis (Q50520431) (← links)
• Parenteral solution of nutritional hepatotrophic factors improves regeneration in thioacetamide-induced cirrhotic livers after partial hepatectomy. (Q51043905) (← links)
• Liver and serum expression of matrix metalloproteinases in asymptomatic pediatric liver transplant recipients. (Q51753688) (← links)
• Impaired proteolysis of collagen I inhibits proliferation of hepatic stellate cells: implications for regulation of liver fibrosis. (Q53591942) (← links)
• Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts. (Q55656994) (← links)
• Enhancement of Silymarin Anti-fibrotic Effects by Complexation With Hydroxypropyl (HPBCD) and Randomly Methylated (RAMEB) β-Cyclodextrins in a Mouse Model of Liver Fibrosis (Q58785915) (← links)
• Resolution of liver fibrosis requires myeloid cell-driven sinusoidal angiogenesis (Q86187033) (← links)
• Effect of prostaglandin analogs: Latanoprost, bimatoprost, and unoprostone on matrix metalloproteinases and their inhibitors in human trabecular meshwork endothelial cells (Q90720630) (← links)
• LOXL2 Inhibition Paves the Way for Macrophage-Mediated Collagen Degradation in Liver Fibrosis (Q91973497) (← links)